Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
23.01
-2.32 (-9.16%)
At close: May 15, 2026, 4:00 PM EDT
21.01
-2.00 (-8.69%)
After-hours: May 15, 2026, 7:59 PM EDT
Cue Biopharma Employees
Cue Biopharma had 29 employees as of December 31, 2025. The number of employees decreased by 12 or -29.27% compared to the previous year.
Employees
29
Change (1Y)
-12
Growth (1Y)
-29.27%
Revenue / Employee
$947,103
Profits / Employee
-$917,310
Market Cap
74.91M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | -12 | -29.27% | 29 | 0 |
| Dec 31, 2024 | 41 | -12 | -22.64% | 41 | 0 |
| Dec 31, 2023 | 53 | 1 | 1.92% | 53 | 0 |
| Dec 31, 2022 | 52 | -7 | -11.86% | 51 | 1 |
| Dec 31, 2021 | 59 | 7 | 13.46% | 57 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Acrivon Therapeutics | 76 |
| PolyPid | 75 |
| eXoZymes | 32 |
| PDS Biotechnology | 24 |
| Gain Therapeutics | 21 |
| Atara Biotherapeutics | 14 |
| MAIA Biotechnology | 13 |
CUE News
- 1 day ago - Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments - GlobeNewsWire
- 8 days ago - Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 11 days ago - Cue Biopharma trading resumes - TheFly
- 11 days ago - Cue Biopharma trading halted, volatility trading pause - TheFly
- 14 days ago - Why Is Cue Biopharma Stock Up Today? - TipRanks
- 15 days ago - Cue Biopharma appoints Shao-Lee Lin as CEO - TheFly
- 15 days ago - Cue Biopharma announces $30M private placement - TheFly
- 15 days ago - Cue Biopharma Announces $30 Million Private Placement - GlobeNewsWire